Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 12, 2007, Pages 4515-4517

  Shi, Ruiru ^a,b   Zhang, Jianyuan ^c   Otomo, Koji ^a   Zhang, Guolong ^b   Sugawara, Isamu ^a  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b Department of Cardiology   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; OFLOXACIN; RIFAMPICIN;

ARTICLE; BACTERIUM ISOLATE; CHINA; CORRELATION ANALYSIS; DRUG SENSITIVITY; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CHINA; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; PENTOSYLTRANSFERASES; RIFAMPIN; TUBERCULOSIS;

EID: 36749010141     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00416-07     Document Type: Article

References (15)

1. Chan, E. D., D. Chatterjee, M. D. Iseman, and L. B. Heifets. 2004. Pyrazinamide, ethambutol, ethionamide, and aminoglycosides, p. 778. In W. N. Rom and S. M. Garay (ed.), Tuberculosis, 2nd ed. Lippincott Williams & Wilkins, Philadelphia, PA.
2. Forbes, M., N. A. Kuck, and E. A. Peets. 1962. Mode of action of ethambutol. J. Bacteriol. 84:1099-1103.
3. Hazbon, M. H., M. Bobadilla del Valle, M. I. Guerrero, M. Varma-Basil, I. Filliol, M. Cavatore, R. Colangeli, H. Saft, H. Billman-Jacobe, C. Lavender, J. Fyfe, L. Garcia-Garcia, A. Davidow, M. Brimacombe, C. I. Leon, T. Porras, M. Bose, F. Chaves, K. D. Eisenach, J. Sifuentes-Osornio, A. Ponce de Leon, M. D. Cave, and D. Alland. 2005. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob. Agents Chemother. 49:3794-3802.
4. Lee, A. S., S. N. Othman, Y. M. Ho, and S. Y. Wong. 2004. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 48:4447-4449.
5. Mazars, E., S. Lesjean, A. L. Banuls, M. Gilbert, V. Vincent, B. Gicquel, M. Tibayrenc, C. Locht, and P. Supply. 2001. High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tubercidosis molecular epidemiology. Proc. Natl. Acad. Sci. USA 98:1901-1906.
6. Mokrousov, L, N. V. Bhanu, P. N. Sufiys, G. V. Kadival, S. F. Yap, S. N. Cho, A. M. Jordaan, O. Narvskaya, U. B. Singh, H. M. Gomes, H. Lee, S. P. Kulkarni, K. C. Lim, B. K. Khan, D. van Soolingen, T. C. Victor, and L. M. Schouls. 2004. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. J. Microbiol. Methods 57:323-335.
7. Mokrousov, I., T. Otten, B. Vyshnevskiy, and O. Narvskaya. 2002. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from northwestern Russia: implications for genotypic resistance testing. J. Clin. Microbiol. 40:3810-3813.
8. Rinder, H., K. T. Mieskes, E. Tortoli, E. Richter, M. Casai, M. Vaquero, E. Cambau, K. Feldmann, and T. Loscher. 2001. Detection of embB codon 306 mutations in ethambutol resistant Mycobacterium tuberculosis directly from sputum samples: a low-cost, rapid approach. Mol. Cell. Probes 15:37-42.
9. Shi, R., K. Otomo, H. Yamada, T. Tatsumi, and I. Sugawara. 2006. Temperature-mediated heteroduplex analysis for the detection of drug-resistant gene mutations in clinical isolates of Mycobacterium tuberculosis by denaturing HPLC, SURVEYOR nuclease. Microbes Infect 8:128-135.
10. Shi, R., J. Zhang, C. Li, Y. Kazumi, and I. Sugawara. 2006. Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing. J. Clin. Microbiol. 44:4566-4568.
11. Sreevatsan, S., K. E. Stockbauer, X. Pan, B. N. Kreiswirth, S. L. Moghazeh, W. R. Jacobs, Jr., A. Telenti, and J. M. Musser. 1997. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob. Agents Chemother. 41:1677-1681.
12. Sugawara, I., K. Otomo, H. Yamada, G. Wang, C. Du, R. Shi, and G. Zhang. 2005. The molecular epidemiology of ethambutol-resistant Mycobacterium tuberculosis in Henan Province, China. Jpn. J. Infect. Dis. 58:393-395.
13. Telenti, A., W. J. Philipp, S. Sreevatsan, C. Bernasconi, K. E. Stockbauer, B. Wieles, J. M. Musser, and W. R. Jacobs, Jr. 1997. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat. Med. 3:567-570.
14. Tracevska, T., I. Jansone, A. Nodieva, O. Marga, G. Skenders, and V. Baumanis. 2004. Characterization of rpsL, rrs and embB mutations associated with streptomycin and ethambutol resistance in Mycobacterium tuberculosis. Res. Microbiol. 155:830-834.
15. Van Rie, A. , R. Warren, I. Mshanga, A. M. Jordaan, G. D. van der Spuy, M. Richardson, J. Simpson, R. P. Gie, D. A. Enarson, N. Beyers, P. D. van Helden, and T. C. Victor. 2001. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol. 39:636-641.